Core Insights - Jyong Biotech Ltd. is a Taiwan-based biotechnology company focused on developing innovative plant-derived drugs for urinary system diseases, targeting markets in the U.S., EU, and Asia [1][3] - The chairwoman and CEO, Fu Feng Kuo, will speak at The 2025 Global Business Forum, discussing how Taiwan's biotech and medical industries can align with global trends [2][3] Company Overview - Jyong Biotech Ltd. was founded in 2002 and has developed integrated capabilities across all key drug development functions, including drug discovery, clinical trials, regulatory affairs, manufacturing, and commercialization [3] - The company is advancing several botanical drug candidates, including its primary candidate BOTRESO and other clinical and preclinical candidates [3] Event Details - The Global Business Forum aims to facilitate direct dialogue between U.S. biotech decision-makers and Taiwan's leading drug development enterprises, focusing on strategic themes such as innovative drug technology development, cross-border clinical collaboration, and strategic capital deployment [2][6]